Biosynthesis of elsamicin A, a novel antitumor antibiotic
K S Lam1, J A Veitch, S Forenza
1Bristol-Myers Company, Pharmaceutical Research and Development Division, Wallingford, Connecticut 06492.
Abstract:
The 1H noise-decoupled 13C-nmr spectrum of elsamicin A [1] prepared from the cultures of an unknown actinomycete species (ATCC 39417) supplemented with [1-13C]acetate and [2-13C]acetate showed enrichment of all 19-carbons in the aglycone. In addition, L-[methyl-13C]methionine- and D-[1-13C]glucose-supplemented cultures enriched the carbons of the two methyl groups on the disaccharide moiety and the C-1 carbons of the disaccharide, respectively. The results demonstrated that the aglycone of elsamicin A is derived entirely from acetate and the disaccharide portion is biosynthesized from two units of glucose and methionine.
Related Concept Videos
Biosynthesis of Lipids
Production of Antibiotics
Inhibitors of Bacterial Protein Synthesis
Antifungal Agents


